Sign inJoin waitlistJoin the waitlist

Nicole Schmitt

Professor and Vice Chair of Research · Emory University School of Medicine

Credentials: · · · · · · ·

History

Research · Emory University School of Medicine
Present
Translational Research · Emory University School of Medicine
Present
Head and Neck Program · Winship Cancer Institute at Emory Midtown
Present

University of Pittsburgh
2009–2010
Otolaryngology – Head and Neck Surgery
University of Washington School of Medicine
2007–2009
General Surgery
University of Washington School of Medicine
2006–2007
Emory University School of Medicine
2002–2006

Research

Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models
Clinical Cancer Research · 2020 · 250 citations
Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer
OncoImmunology · 2017 · 241 citations
PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer
Cancer Research · 2017 · 205 citations

Nabil Saba
24 papers
Conor Steuer
15 papers
Mihir Patel
15 papers
Jennifer Gross
14 papers · 1 as a fellow
Azeem Kaka
13 papers
Brian Boyce
11 papers
Robert Ferris
11 papers
William Stokes
11 papers
Dong Shin
10 papers
Harry Baddour
10 papers
James Bates
10 papers
ME
Mark El-Deiry
10 papers

Grants

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss in Head and Neck Cancer Patients
National Institute on Deafness and Other Communication Disorders · U01
Contact PI · $1.5M · Emory University
2023–2029
Patient Oriented Research in Communication and Swallowing Disorders
National Institute on Deafness and Other Communication Disorders · K24
Contact PI · $433K · Emory University
2024–2029
Systemic/Abscopal Anti-Tumor Immune Responses During IAP Antagonism and Radiation
National Institute of Dental and Craniofacial Research · R21
Contact PI · $430.4K · Emory University
2025–2027
The Role of STAT1 in Cisplatin-Induced Hair Cell Death
National Institute on Deafness and Other Communication Disorders · F32
Contact PI · $46.2K · University of Washington
2008–2009

Clinical trials

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Principal investigator · Recruiting
Emory University
2025–2029
Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer
Principal investigator · Active not recruiting · Early phase 1
Emory University
2022–2027